Phase II clinical trial of gadoteridol injection, a low-osmolal magnetic resonance imaging contrast agent. [electronic resource]
Producer: 19920923Description: S16-21 p. digitalISSN:- 0020-9996
- Adult
- Aged
- Brain -- pathology
- Brain Neoplasms -- diagnosis
- Contrast Media -- administration & dosage
- Dose-Response Relationship, Drug
- Drug Evaluation
- Drug Tolerance
- Gadolinium -- administration & dosage
- Heterocyclic Compounds -- administration & dosage
- Humans
- Magnetic Resonance Imaging
- Middle Aged
- Organometallic Compounds -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.